Log In
Print
BCIQ
Print
Print this Print this
 

XmAb2513

  Manage Alerts
Collapse Summary General Information
Company Xencor Inc.
DescriptionHumanized mAb against CD30
Molecular Target CD30
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today